Chowist Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis hands investors Alcon spin-off, $5 billion ... - AOL

    www.aol.com/news/novartis-hands-investors-alcon...

    Novartis plans to spin off its Alcon eye care business to shareholders and buy back up to $5 billion in stock as Chief Executive Vas Narasimhan refocuses the Swiss group on prescription drugs.

  3. Novartis to Spin-Off Alcon as Separate Trading Company - AOL

    www.aol.com/news/novartis-spin-off-alcon...

    Novartis announces that it will spin-off its ophthalmology division, Alcon, into a separately-traded standalone company in order to focus on its legacy pharmaceuticals business.

  4. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    On July 8, 2010, Alcon's independent director committee (IDC) had set up a $50 million litigation trust to ensure company's minority shareholders get the best deal from bidder Novartis AG. [15] On April 9, 2019, Alcon completed a 100% spin-off from Novartis. [4] [16] [17] The new standalone company is worth up to 28 billion Swiss francs. [18]

  5. Novartis' Sandoz dips on debut after lower than expected ...

    www.aol.com/news/novartis-completes-sandoz-spin...

    The debut made Sandoz the largest new entrant to the Swiss stock exchange since 2019, when another Novartis spin-off, eyecare company Alcon, was valued at about 28 billion francs.

  6. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [127] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73] Sandoz: As of 2013, Sandoz has been recognized as the world's second-largest generic drug company.

  7. Sandoz - Wikipedia

    en.wikipedia.org/wiki/Sandoz

    Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [ 4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer ...

  8. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July ...

  9. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    1. 2015. Pfizer. Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [ 12][ 13] Had this transaction been completed, this would have been the largest within this industry.